University Hospitals of Cleveland
Cleveland, Ohio, 44106, United States
NCT Number: NCT00194090
A paced 20-minute walk is a reproducible model for acute pain in knee osteoarthritis
Looking for future studies?
Notify Me45 year–85 year
All sexes
Interventional
Phase 4
Cleveland, Ohio, 44106, United States
This is a randomizd, placbo-controlled, crossover trial comparing a single dose of celecoxib to placebo measuring the time to onset of acute pain in a paced 20-minute walk.
40 subjects will be enrolled
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Knee osteoarthritis by ACR clinical criteria Pain of at least 40 mm by VAS at baseline
-
Exclusion criteria
Non-pregant, non-lactating Able to stop active arthritis medication for washout Cardiovascular risk factors Abnormal EKG -
University Hospitals Cleveland Medical Center
Other
A Double-blind, Placebo-controlled, Crossover Pilot Study of the Efficacy of Celecoxib 200 mg qd in Relieving Pain and Walking Dysfunction in Osteoarthritis of the Knee
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02905799
Arthritis, Joint Diseases
Paris, France
View Trial DetailsNCT07403383
Arthritis, Joint Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05618782
Arthritis, Connective Tissue Diseases
Brno, Czechia
View Trial DetailsNCT04390932
Arthritis, Joint Diseases
Temuco, Chile
View Trial Details